Yuji Makino
Hokuriku University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yuji Makino.
Archive | 1996
Tsuneji Nagai; Mariko Morishita; Isao Morishita; Yoshiki Suzuki; Yuji Makino
From the pharmaceutical point of view, the bioavailability, that is the amount and rate of absorption, is the most important factor determining the drug quality with respect to its efficacy and safety. Then, the bioavailability is controlled by well-designed dosage forms, for which interactions with surrounding components are applicable. Practically there are afforded various possibilities of modification of the interaction and then of control of drug delivery by a design of dosage forms, using polymers. The present talk will contain, as example, enteral delivery of insulin by Eudragit microsphere with protease inhibitors, topical mucosal drug delivery systems with adhesive polymers, and nasal delivery of salmon calcitonin by functional powder preparations using microcystalline cellulose. These polymers are guaranteed already as pharmaceutically safe ones.
Archive | 1996
Masahiko Doi; Takao Fujii; Yuji Makino; Kyoji Ogawa; 雅彦 土肥; 恭司 小川; 隆雄 藤井
Archive | 1996
Masahiko Doi; Takao Fujii; Yuji Makino; Yoshihisa Nishibe; 雅彦 土肥; 隆雄 藤井; 義久 西部
Archive | 1993
Masahiko Doi; Yuji Makino; Yoshihisa Nishibe; Yoshiki Suzuki; 雅彦 土肥; 義久 西部; 嘉樹 鈴木
Archive | 2001
Hideo Matsugi; Masahiko Dohi; Yasuhide Uejima; Yuji Makino
Archive | 1996
Masahiko Doi; Takao Fujii; Yuji Makino; Yoshihisa Nishibe; 雅彦 土肥; 隆雄 藤井; 義久 西部
Biological & Pharmaceutical Bulletin | 1997
Takayuki Nagai; Yoshihisa Nishibe; Yuji Makino; Tsuyoshi Tomimori; Haruki Yamada
Archive | 1994
Takao Fujii; Yuji Makino; Masahiro Sakagami; Seishi Sakon; 聖之 左近; 隆雄 藤井; 正裕 阪上
Archive | 1997
Wataru Kinoshita; Yuji Makino; 渉 木下
Archive | 1995
Ichiro Katayama; Yuji Makino; Hiroaki Sato; Yukihiro Tadaki; Mineo Uozumi; 裕明 佐藤; 行啓 只木; 一朗 片山; 峰男 魚住